Exane Derivatives’s Zions Bancorporation ZION Stock Holding History

Exane Derivatives’s Portfolio ZION Stock Details ZION Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,120	Closed	-$139K	–	1036
2022 Q1	$139K	Buy	+2,120	New	+$145K	0.04%	420
2021 Q4	–	Sell	-1,799	Closed	-$111K	–	1086
2021 Q3	$111K	Buy	1,799 +683	+61%	+$37.5K	0.03%	508
2021 Q2	$57.4K	Buy	+1,116	New	+$62.5K	0.01%	634
2019 Q2	–	Sell	-1	Closed	-$45	–	733
2019 Q1	$45	Sell	1 -246	-100%	-$11.7K	﹤0.01%	599
2018 Q4	$10.1K	Hold	247	–	–	﹤0.01%	462
2018 Q3	$12.4K	Buy	247 +1	+0.4%	+$53	﹤0.01%	436
2018 Q2	$13K	Sell	246 -5,186	-95%	-$286K	﹤0.01%	450
2018 Q1	$283K	Buy	5,432 +121	+2%	+$6.51K	0.06%	216
2017 Q4	$270K	Buy	5,311 +2,343	+79%	+$112K	0.05%	213
2017 Q3	$140K	Sell	2,968 -29	-1%	-$1.29K	0.03%	223
2017 Q2	$132K	Buy	+2,997	New	+$123K	0.03%	242

Other funds holding ZION

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Exane Derivatives's ZION Position: Q2 2022 in Review

Exane Derivatives sold out of Zions Bancorporation (ZION) in Q2 2022, closing a stake of 2,120 shares — an estimated $139K sold.

Exane Derivatives first reported a position in ZION in Q2 2017 and held it in 11 quarters. The position peaked at $283K in Q1 2018. 489 funds tracked by Wall St. Rank hold ZION as of Q2 2022.

Exane Derivatives reported no remaining Zions Bancorporation position as of Q2 2022 after selling out during the quarter.
Exane Derivatives sold 2,120 Zions Bancorporation shares in Q2 2022, an estimated $139K.
Exane Derivatives first reported a position in Zions Bancorporation in Q2 2017 and held it in 11 quarters.
Exane Derivatives's Zions Bancorporation position peaked at $283K in Q1 2018.
489 funds tracked by Wall St. Rank held Zions Bancorporation as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.